Does Electromyography Improve Precision and Reliability of Neuromuscular Monitoring in Paediatric Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

64 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-09-20

Study Completion Date

2024-12-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Neuromuscular monitoring is used as a standard surveillance method of neuromuscular function to ensure full recovery at the end of anaesthesia. The currently available devices properly provide respective information in adults but not in children. Furthermore, response to neuromuscular blocking agents differs between adults and children due to age-related differences in body composition, physiological function, and acetylcholine receptor density.

Recently, electromyographic (EMG) technologies to monitor neuromuscular function were increasingly developed including disposables for nerve stimulation and measurement of the compound muscle action potential in children. However, it is still unclear whether the precision and reliability of these devices is superior to the currently available neuromuscular monitoring for children based on kinemyography (KMG).

The ETCETERA study will test the hypothesis that neither EMG nor KMG provides inferior train-of-four readings to the respective reference method in infants and children below five years.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography

NCT06409260

Neuromuscular Blockade

RECRUITING NA

Electromyographic Monitoring and Postoperative Recovery

NCT03891381

Postoperative Residual Neuromuscular Blockade

TERMINATED NA

MUSCLE EFFECTS OF NEUROMUSCULAR ELECTROSTIMULATION IN MECHANICALLY VENTILATED PATIENTS IN AN ICU

NCT06409611

Intensive Care Unit Acquired Weakness

RECRUITING NA

Electromyographic (EMG) Biofeedback Training in Zone I-III Flexor Tendon Injuries

NCT04237415

Flexor Tendon Rupture Hand Therapy

COMPLETED NA

Mechanomyography Reloaded? A Randomized Prospective Agreement Study

NCT06230653

Neuromuscular Blockade

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The ETCETERA trial is a randomized clinical agreement study which will prospectively enrol sixty-four children below five years of age scheduled for elective, non-cardiac surgery requiring general anaesthesia and neuromuscular blockade for optimisation of surgical conditions.

The children's neuromuscular function is measured on one hand with EMG and on the other hand with KMG in a randomised fashion. Additionally, randomisation will be stratified upon age groups: 1) neonates: birth to \<28 days, 2) infants 28 days to ≤3 months, 3) toddlers: \>3 months to ≤2 years, 4) children \>2 years to \<5 years.

Based on the high failure rate of currently available neuromuscular monitoring devices in infants and neonates, in this randomised agreement study we will primarily compare precision and reliability of EMG and KMG-measured Train-of-Four (TOF) values during spontaneous recovery from a rocuronium-induced neuromuscular blockade in neonates, infants, toddlers, and children \<5 years using the age-appropriate paediatric sensors.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuromuscular Blockade, Residual Postoperative Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Measurement of the muscle velocity for the assessment of neuromuscular function

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* children and infants \< 5 years
* non-cardiac surgery requiring general anaesthesia and neuromuscular blockade
* signed informed written consent
* American Society of Anesthesiologists physical status \<4
* intraoperative positioning with access to both arms

Exclusion Criteria

* allergy to neuromuscular blocking agents
* allergy to neuromuscular monitoring adhesive electrode
* neurologic disease
* surgical procedures outside the operating room
* children receiving neuromuscular blocking agents immediately before surgery

Minimum Eligible Age

1 Hour

Maximum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No